Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, <em class="a-plus-plus">i.e.</em>, increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and <em class="a-plus-plus">ex vivo</em> molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes.</p>

The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations

Applications of MALDI-TOF mass spectrometry in clinical proteomics

Cellular resolution in clinical MALDI mass spectrometry imaging: the latest advancements and current challenges

MALDI Mass Spectrometry Imaging: A Potential Game-Changer in a Modern Microbiology

Applications of MALDI-MS/MS-Based Proteomics in Biomedical Research

Matrix-assisted laser desorption ionisation (MALDI) mass spectrometry (MS): basics and clinical applications

MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology

Mass spectrometry for translational proteomics: progress and clinical implications

Proteome Imaging: From Classic to Modern Mass Spectrometry-Based Molecular Histology

Future technology insight: mass spectrometry imaging as a tool in drug research and development

Clinical applications of mass spectrometry‐based proteomics in cancer: where are we?

Peptidomics and proteomics based on CE‐MS as a robust tool in clinical application: The past, the present, and the future

Recent advances in mass spectrometry based clinical proteomics: applications to cancer research

Emerging mass spectrometry-based proteomics methodologies for novel biomedical applications

From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications

Emerging Technologies in Mass Spectrometry Imaging

Current Status of Matrix-Assisted Laser Desorption/Ionization–Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology

Recent advances in clinical proteomics using mass spectrometry

Advances in MALDI Mass Spectrometry Imaging Single Cell and Tissues